Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001548233-12-000017
Filing Date
2012-10-12
Accepted
2012-10-12 09:29:35
Documents
11
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10K ANNUAL REPORT annual2012_10k.htm 10-K 2646083
2 EXHIBIT 31-1 auditreport_ex31z1.htm EX-31 10330
3 EXHIBIT 31-2 auditreport_ex31z2.htm EX-31 10567
4 EXHIBIT 32-1 auditreport_ex32z1.htm EX-32 5242
5 EXHIBIT 32-2 auditreport_ex32z2.htm EX-32 6551
  Complete submission text file 0001548233-12-000017.txt   10258804

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ctix-20120630.xml EX-101.INS 1454828
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ctix-20120630.xsd EX-101.SCH 74623
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ctix-20120630_cal.xml EX-101.CAL 27366
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ctix-20120630_def.xml EX-101.DEF 348685
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ctix-20120630_lab.xml EX-101.LAB 486028
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ctix-20120630_pre.xml EX-101.PRE 455969
Mailing Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915
Business Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915 (978)-633-3623
Cellceutix CORP (Filer) CIK: 0001355250 (see all company filings)

EIN.: 134303398 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 000-52321 | Film No.: 121141120
SIC: 2834 Pharmaceutical Preparations